Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc.

80.50
EUR
-1.50
(-1.83%)
-3.46EPS
4.36BMarket Cap
Mar 16Next Earn

Dianthus Therapeutics, Inc. Documents

Q3 FY2022 · Quarterly report

November 3, 2022 · 99 pages

Read Dianthus Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this quarterly report
Create a free account to start reading

Full documents are included with Professional

Q3 FY2022 documents